Testosterone Cypionate Half-Life Guide

Testosterone cypionate has a half-life of approximately 8 days. That single number governs how your blood levels rise and fall between injections, why some dosing schedules produce more stable levels than others, and when your bloodwork needs to be drawn to give your prescriber meaningful data.

Most TRT patients know their dose in milligrams but don't think much about what happens to that testosterone after it leaves the syringe. Understanding the pharmacokinetic curve — when levels peak, how fast they drop, and what the trough looks like — makes your dosing protocol make sense instead of feeling like an arbitrary schedule.

What "Half-Life" Actually Means

Half-life is the time it takes for the concentration of a drug in your bloodstream to drop to half its peak value. For testosterone cypionate, that's roughly 8 days.

Here's what that looks like in practice. Say you inject 200 mg of testosterone cypionate on Monday:

• Day 1-2: Blood testosterone rises rapidly as the oil depot at the injection site releases testosterone into your bloodstream. Levels peak at approximately 24-48 hours post-injection.
• Day 8: Roughly half the dose has been metabolized. If your peak was around 1200 ng/dL, you're now somewhere around 600 ng/dL (simplified — the math is more complex with absorption dynamics, but the principle holds).
• Day 16: Another half-life has passed. Roughly one-quarter of the original dose remains active.
• Day 24: One-eighth remaining.
• Day 40-48: After 5-6 half-lives, the dose is effectively cleared from your system.

This decay curve is why you inject on a regular schedule — each new injection re-ups the supply before the previous dose has fully cleared, creating overlapping concentration curves that maintain your levels within a target range.

Peak and Trough: The Weekly Cycle

On a standard once-weekly injection protocol, your testosterone levels follow a predictable sawtooth pattern:

Peak (24-48 hours post-injection): The highest your levels will reach during the cycle. For a typical TRT dose of 100-200 mg/week, peak levels may reach 800-1400 ng/dL depending on your metabolism, body composition, injection site, and individual absorption characteristics.

Mid-cycle (Day 3-4): Levels have begun declining but are still well above the trough. This is where many patients feel their best — past the initial spike but before the drop becomes noticeable.

Trough (Day 7, pre-injection): The lowest point in the cycle. Trough levels on a weekly 100-200 mg protocol typically fall in the 400-700 ng/dL range, though individual variation is significant. If your trough drops below the reference range (roughly 300-1000 ng/dL depending on the lab), you may notice symptoms returning in the day or two before your next injection.

The "Day Before Injection" Dip

Many TRT patients report noticing a shift in energy, mood, or libido in the 24-48 hours before their next injection. This corresponds to the trough of the pharmacokinetic curve. The steeper the drop from peak to trough, the more perceptible this effect. This is one of the primary motivations for split dosing.

Weekly vs. Split Dose: The Pharmacokinetic Argument

The 8-day half-life creates a fundamental question: is it better to inject your full weekly dose once, or split it into two smaller injections?

Once-Weekly Injection

Example: 150 mg every 7 days.

Advantage: Simple schedule. One injection per week. Fewer needle sticks.

Disadvantage: The peak-to-trough swing is larger. You get a higher peak (which can increase estradiol conversion and hematocrit) and a lower trough (which may cause end-of-week symptom return). The ratio of peak to trough on a weekly schedule is roughly 2:1 to 3:1 depending on individual metabolism.

Split Dose (Twice-Weekly)

Example: 75 mg every 3.5 days (Monday morning and Thursday evening, for instance).

Advantage: Significantly flatter blood level curve. The peak is lower and the trough is higher, reducing the total swing. Most patients on a split protocol report fewer mood fluctuations, less end-of-cycle fatigue, and more consistent energy throughout the week. Lower peaks also mean less aromatization to estradiol and potentially lower hematocrit impact.

Disadvantage: Twice the injection frequency. More needle sticks, more site rotation to manage, and a slightly more complex schedule to track.

How the Numbers Compare

For a 150 mg weekly dose with an 8-day half-life, approximate steady-state values:

These are illustrative estimates — individual values depend on SHBG, albumin binding, body fat percentage, injection site vascularity, and metabolic rate. But the pattern is consistent: split dosing cuts the peak-to-trough swing by roughly 50-70%.

Which Is Right for You?

This is a clinical decision between you and your prescriber, not a self-optimization exercise. Some patients do perfectly well on weekly injections with no perceptible symptoms at the trough. Others clearly benefit from the stability of a split protocol. Lab values, symptom logs, and your provider's assessment should drive this decision.

How Half-Life Affects Steady State

When you start TRT or change your dose, you don't reach stable blood levels immediately. It takes approximately 4-5 half-lives for testosterone cypionate to reach steady state — the point where the amount entering your system with each injection equals the amount being cleared.

For testosterone cypionate, that's roughly 32-40 days. This is why your prescriber typically waits 4-6 weeks after starting or adjusting your dose before ordering follow-up bloodwork. Labs drawn at week 2 don't reflect what your levels will look like at steady state.

Timing Your Bloodwork

Lab timing relative to your injection cycle dramatically affects the numbers on the report. The same patient on the same dose can produce a testosterone level of 500 ng/dL or 1100 ng/dL depending entirely on when blood was drawn.

Trough Testing (Most Common)

Draw blood immediately before your next scheduled injection — within a few hours of when you would normally inject. This gives the lowest point in your cycle and is the standard timing recommended by the Endocrine Society guidelines.

Why trough testing matters: If your trough is within the target range, you know your levels are adequate at their lowest point. Everything above the trough (the entire rest of the week) is guaranteed to be at or above target.

Mid-Cycle Testing

Some clinicians prefer mid-cycle labs (approximately 3-4 days after injection on a weekly protocol). This gives a level that's closer to your average blood concentration rather than the minimum. It's less standard but can be useful for assessing average exposure.

Peak Testing

Drawing blood 24-48 hours after injection gives your peak level. This is less common for routine monitoring but may be requested if your prescriber is concerned about supraphysiological peaks — especially relevant for hematocrit monitoring and estradiol assessment.

Consistency Is the Rule

Whichever timing you and your provider choose, use the same timing for every blood draw. Comparing a trough from one lab to a mid-cycle from the next is meaningless. Note your injection day and time, and your blood draw day and time, in your tracking log so there's no ambiguity.

Other Testosterone Esters: A Half-Life Comparison

Testosterone cypionate is the most commonly prescribed ester in the United States, but it's not the only option. The ester determines the half-life:

Testosterone enanthate and cypionate have nearly identical half-lives and are clinically interchangeable for most purposes. The choice between them is often a matter of regional availability and prescriber preference. Testosterone undecanoate (available as Nebido or Aveed) has a much longer half-life, allowing injections every 10-14 weeks, but requires a large-volume intramuscular injection and is less common in the US.

Why Tracking Matters for Half-Life Management

The pharmacokinetics only work as designed when the injections are consistent. A dose that's 2 days late shifts your entire concentration curve — your trough drops lower than expected, and the next peak overshoots relative to the shifted baseline. Over multiple cycles, inconsistent timing creates erratic blood levels that make lab interpretation difficult and symptom management unreliable.

Things worth tracking at each injection:

• Date and time — the clock starts here for pharmacokinetic purposes
• Dose in mg — confirms consistency; flags any prescription changes
• Injection site — critical for IM injection site rotation on TRT
• Lab draw dates — note both the date and the time relative to your last injection

Done Dose tracks injection timing alongside dose amounts and site rotation, so when bloodwork results come back, you can see exactly where in the cycle the draw occurred. That context turns a lab number into actionable information.

Practical Implications

The 8-day half-life of testosterone cypionate means:

• Weekly injections are pharmacologically reasonable but produce noticeable peak-trough swings in many patients.
• Split dosing (every 3.5 days) smooths the curve and is increasingly recommended by TRT-focused clinicians.
• Steady state takes about 5 weeks — don't judge a new dose or protocol until you've been on it for at least that long.
• Lab timing changes the numbers — always draw at the same point in your injection cycle, and record when that was.
• Consistency matters more than precision — injecting reliably on schedule has a bigger impact on stable levels than optimizing to the exact hour.

Your prescriber set your dose based on clinical targets. The half-life tells you how your body processes that dose between injections. Understanding both puts you in a better position to follow the protocol accurately and to have informed conversations with your provider when adjustments are needed.